Latest News, Updates & Breaking Headlines
Pfizer is poised to acquire US-based biotechnology firm Metsera in a $10 billion deal, after winning a heated bidding battle against Danish drugmaker Novo Nordisk, which has now withdrawn from the race, AFP reported.Metsera, which specialises in obesity treatments, said in a statement that Pfizer’s improved offer of $86.25 per share had been unanimously approved…
Danish pharmaceutical giant Novo Nordisk, the maker of obesity drugs Ozempic and Wegovy, lowered its 2025 sales outlook for the fourth time this year on Wednesday after reporting tepid third-quarter results.The company, which appointed Mike Doustdar as CEO in August, now expects full-year sales growth of 8 to 11 per cent, down from a previous…
Denmark’s Novo Nordisk, the pharmaceutical giant behind blockbuster drugs Ozempic and Wegovy, is set for a major boardroom shake-up amid internal disagreements and growing competitive pressure in the weight-loss drug market. The company on Tuesday announced that it will replace more than half of its 12-member board, including its chair, following a dispute with its…
